Cantor Fitzgerald Brokers Cut Earnings Estimates for APLS
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Analysts at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for Apellis Pharmaceuticals in a report released on Thursday, May 8th. Cantor Fitzgerald analyst S. Seedhouse now expects that the company will earn ($2.38) per share for the year, down from their prior forecast of ($0.94). […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Analysts at Cantor Fitzgerald reduced their FY2025 earnings per share estimates for Apellis Pharmaceuticals in a report released on Thursday, May 8th. Cantor Fitzgerald analyst S. Seedhouse now expects that the company will earn ($2.38) per share for the year, down from their prior forecast of ($0.94). […]
